Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Li, Lianhong  [Clear All Filters]
2023
Zhang J, Liu D, Feng Z, Mao J, Zhang C, Lu Y, Li J, Zhang Q, Li Q, Li L. Retraction notice to "MicroRNA-138 modulates metastasis and EMT in breast cancer cells by targeting vimentin" [Biomed. Pharmacother. 77 (2016) 135-141]. Biomed Pharmacother. 2023:115372.
2019
Liu X, Lu Y, Xu Y, Hou S, Huang J, Wang B, Zhao J, Xia S, Fan S, Yu X, et al. Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer. Cancer Lett. 2019.
2018
Wu D, Zhang J, Lu Y, Bo S, Li L, Wang L, Zhang Q, Mao J. miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1. Cancer Gene Ther. 2018.
Liu L, Wang Q, Mao J, Qin T, Sun Y, Yang J, Han Y, Li L, Li Q. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells. Chem Biol Interact. 2018.
2016
Zhang C, Lu Y, Li Q, Mao J, Hou Z, Yu X, Fan S, Li J, Gao T, Yan B, et al. Salinomycin Suppresses TGF-β1-Induced Epithelial-to-Mesenchymal Transition in MCF-7 Human Breast Cancer Cells. Chem Biol Interact. 2016.
2015
Lu Y, Zhang C, Li Q, Mao J, Ma W, Yu X, Hou Z, Li L. [Inhibitory effect of salinomycin on human breast cancer cells MDA-MB-231 proliferation through Hedgehog signaling pathway]. Zhonghua Bing Li Xue Za Zhi. 2015;44(6):395-398.